Literature DB >> 21383043

Diagnostic potential of saliva: current state and future applications.

Tina Pfaffe1, Justin Cooper-White, Peter Beyerlein, Karam Kostner, Chamindie Punyadeera.   

Abstract

BACKGROUND: Over the past 10 years, the use of saliva as a diagnostic fluid has gained attention and has become a translational research success story. Some of the current nanotechnologies have been demonstrated to have the analytical sensitivity required for the use of saliva as a diagnostic medium to detect and predict disease progression. However, these technologies have not yet been integrated into current clinical practice and work flow. CONTENT: As a diagnostic fluid, saliva offers advantages over serum because it can be collected noninvasively by individuals with modest training, and it offers a cost-effective approach for the screening of large populations. Gland-specific saliva can also be used for diagnosis of pathology specific to one of the major salivary glands. There is minimal risk of contracting infections during saliva collection, and saliva can be used in clinically challenging situations, such as obtaining samples from children or handicapped or anxious patients, in whom blood sampling could be a difficult act to perform. In this review we highlight the production of and secretion of saliva, the salivary proteome, transportation of biomolecules from blood capillaries to salivary glands, and the diagnostic potential of saliva for use in detection of cardiovascular disease and oral and breast cancers. We also highlight the barriers to application of saliva testing and its advancement in clinical settings.
SUMMARY: Saliva has the potential to become a first-line diagnostic sample of choice owing to the advancements in detection technologies coupled with combinations of biomolecules with clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383043     DOI: 10.1373/clinchem.2010.153767

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  177 in total

1.  The human circadian metabolome.

Authors:  Robert Dallmann; Antoine U Viola; Leila Tarokh; Christian Cajochen; Steven A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-31       Impact factor: 11.205

2.  Development of transcriptomic biomarker signature in human saliva to detect lung cancer.

Authors:  Lei Zhang; Hua Xiao; Hui Zhou; Silverio Santiago; Jay M Lee; Edward B Garon; Jieping Yang; Ole Brinkmann; Xinmin Yan; David Akin; David Chia; David Elashoff; No-Hee Park; David T W Wong
Journal:  Cell Mol Life Sci       Date:  2012-06-12       Impact factor: 9.261

3.  A novel saliva-based microRNA biomarker panel to detect head and neck cancers.

Authors:  Carolina Salazar; Rahul Nagadia; Pratibala Pandit; Justin Cooper-White; Nilanjana Banerjee; Nevenka Dimitrova; William B Coman; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2014-08-26       Impact factor: 6.730

4.  Diagnosis of Trypanosoma cruzi Infection Status using Saliva of Infected Subjects.

Authors:  Nuria Cortes-Serra; Maria-Jesus Pinazo; Leonardo de la Torre; Melina Galizzi; Joaquim Gascon; Juan Manuel Bustamante
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

Review 5.  Wearable biosensors for healthcare monitoring.

Authors:  Jayoung Kim; Alan S Campbell; Berta Esteban-Fernández de Ávila; Joseph Wang
Journal:  Nat Biotechnol       Date:  2019-02-25       Impact factor: 54.908

6.  Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.

Authors:  Noha A Ghallab; Olfat G Shaker
Journal:  Clin Oral Investig       Date:  2016-05-10       Impact factor: 3.573

7.  Recruitment and Collection of Dermal Interstitial Fluid Using a Microneedle Patch.

Authors:  Chandana Kolluru; Mikayla Williams; Jeremy Chae; Mark R Prausnitz
Journal:  Adv Healthc Mater       Date:  2019-01-04       Impact factor: 9.933

Review 8.  Critical overview on the application of sensors and biosensors for clinical analysis.

Authors:  Celine I L Justino; Armando C Duarte; Teresa A P Rocha-Santos
Journal:  Trends Analyt Chem       Date:  2016-04-08       Impact factor: 12.296

9.  Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients.

Authors:  Dmitry A Ovchinnikov; Matthew A Cooper; Pratibala Pandit; William B Coman; Justin J Cooper-White; Patricia Keith; Ernst J Wolvetang; Paul D Slowey; Chamindie Punyadeera
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

10.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.